secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aligos Therapeutics, Inc. (ALGS)
CIK:        0001799448
Form:       8-K
Filed at:   2026-06-26T20:02:26+00:00
Accession:  0001193125-26-285426
Event type: other
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aligos stockholders reelect two Class III directors, approve ESPP amendment adding 500K shares
--------------------------------------------------------------------------------

- Bridget Martell and Carole Nuechterlein elected as Class III directors with 2,092,164 and 2,086,481 votes for, respectively.
- Stockholders approved ESPP amendment increasing share reserve by 500,000 shares to 694,714 total, and eliminating evergreen provision.
- Ratification of Ernst & Young as auditor for fiscal 2026 approved with 3,786,255 votes for.
- Non-binding advisory say-on-pay approved with 2,074,434 votes for; company will hold future advisory votes annually.
- Stockholders voted 2,077,884 for annual frequency of say-on-pay; board adopts annual vote until next advisory vote.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799448/000119312526285426/0001193125-26-285426-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799448/000119312526285426/d70452d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-285426

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer